文献速递产科母胎医学

产后硫酸镁预防抽搐12小时与24小时方案的成本效果分析

12 versus 24 hours of postpartum magnesium sulfate for seizure prophylaxis: A cost-effectiveness analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-10-30

本研究构建决策分析模型,在45,800例子痫前期伴严重特征的产后患者中比较12小时与24小时硫酸镁方案的成效果。

要点

  • 12小时方案较24小时方案子痫病例增加86例(398 vs 312)。
  • 12小时方案镁中毒减少656例(2089 vs 2745),死亡增加0.37例(10.87 vs 10.50)。

核心结论

  • 在子痫前期伴严重特征的产后患者中,12小时硫酸镁方案与24小时方案相比为优势策略(成本更低、效果更好)且具成本效果。

研究设计与样本

  • 决策分析模型,理论队列为45,800例子痫前期伴严重特征的产后患者,概率、成本和效用值来源于文献。

主要发现

  • 12小时方案较24小时方案子痫病例增加86例(398 vs 312),死亡增加0.37例(10.87 vs 10.50)。
  • 12小时方案较24小时方案镁中毒减少656例(2089 vs 2745)。

关键数值与推荐

  • 成本效果阈值为每QALY 100,000美元。
  • 主要结局包括每QALY增量成本、子痫病例、镁中毒和孕产妇死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The approach to prevent eclampsia in the postpartum period utilizes magnesium sulfate but there is no evidence-based standard to guide duration. OBJECTIVES: To assess the cost-effectiveness of an abbreviated 12-hour postpartum magnesium sulfate regimen compared with a standard 24-hour regimen. STUDY DESIGN: A decision-analytic model was constructed to compare a 12-hour regimen with a 24-hour regimen in a theoretical cohort of 45,800 patients with preeclampsia with severe features. Probabilities, costs, and utilities were derived from the literature. Primary outcomes included incremental cost per quality-adjusted life-year (QALY), cases of eclampsia, magnesium toxicity, and maternal death. The cost-effectiveness threshold was $100,000 per QALY. RESULTS: A 12-hour regimen in this theoretical cohort of 45,800 postpartum patients compared with a 24-hour regimen resulted in 86 more cases of eclampsia (398 vs 312) and 0.37 more deaths (10.87 vs 10.50). However, there were 656 fewer cases of magnesium toxicity (2089 vs 2745). Overall, a 12-hour regimen was a dominant strategy that resulted in decreased costs of $21.5 million and increased effectiveness of 17 QALYs. CONCLUSION: In our study, an abbreviated duration of postpartum magnesium sulfate prophylaxis for patients with preeclampsia with severe features was a dominant strategy (lower costs, better outcomes) and cost-effective compared with the standard 24-hour regimen.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Robinson AA, Curl O, Mandelbaum A, et al. 12 versus 24 hours of postpartum magnesium sulfate for seizure prophylaxis: A cost-effectiveness analysis. Am J Obstet Gynecol MFM. 2025. PMID: 41176031. doi:10.1016/j.ajogmf.2025.101819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。